18-month-old Kanav Jangra, hailing from Delhi, is fighting Spinal Muscular Atrophy (SMA) Type 1, a severe genetic disorder affecting motor neurons. SMA Type 1 often proves fatal before age two but aggressive therapy offers hope. Kanav needed a Rs 17.5 crore injection, inspiring a successful crowdfunding effort involving 1.5 lakh donors and celebrity support, ultimately securing the treatment for Rs 10.5 crore. The injection has already shown promising results, allowing Kanav to sit and move his legs.Delhi toddler battling rare SMA disorder
General18-month-old Kanav Jangra, hailing from Delhi, is fighting Spinal Muscular Atrophy (SMA) Type 1, a severe genetic disorder affecting motor neurons. SMA Type 1 often proves fatal before age two but aggressive therapy offers hope. Kanav needed a Rs 17.5 crore injection, inspiring a successful crowdfunding effort involving 1.5 lakh donors and celebrity support, ultimately securing the treatment for Rs 10.5 crore. The injection has already shown promising results, allowing Kanav to sit and move his legs.
Comments